Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-050227
Filing Date
2024-12-16
Accepted
2024-12-16 16:25:19
Documents
46
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 485464
2 ex31-1.htm EX-31.1 20338
3 ex31-2.htm EX-31.2 20178
4 ex32-1.htm EX-32.1 8887
5 ex32-2.htm EX-32.2 9000
  Complete submission text file 0001493152-24-050227.txt   3012076

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pure-20241031.xsd EX-101.SCH 22404
7 XBRL CALCULATION FILE pure-20241031_cal.xml EX-101.CAL 29859
8 XBRL DEFINITION FILE pure-20241031_def.xml EX-101.DEF 112873
9 XBRL LABEL FILE pure-20241031_lab.xml EX-101.LAB 216112
10 XBRL PRESENTATION FILE pure-20241031_pre.xml EX-101.PRE 167261
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 326314
Mailing Address 771 JAMACHA ROAD #512 EL CAJON CA 92019
Business Address 771 JAMACHA ROAD #512 EL CAJON CA 92019 619-596-8600
PURE BIOSCIENCE, INC. (Filer) CIK: 0001006028 (see all company filings)

EIN.: 330530289 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-14468 | Film No.: 241552160
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)